![Quiver Logo](/static/img/logo-icon.png)
![GDTC logo](https://quiver-logos.s3.us-east-2.amazonaws.com/gdtc.png)
CytoMed Therapeutics Limited Ordinary Shares
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GDTC Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of GDTC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GDTC's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to GDTC
Recent picks made for GDTC stock on CNBC
ETFs with the largest estimated holdings in GDTC
Flights by private jets registered to GDTC
![Quiver Logo](/static/img/logo-icon.png)